Pancreatic cancer
Integrative techniques to enhance the immune response in aggressive forms of the disease.
About the disease
Pancreatic cancer is one of the hardest oncology challenges. The tumor metastasizes early, responds poorly to chemotherapy, and barely attracts the immune system's attention. Such tumors are called 'cold'. Immunotherapy tries to overcome that coldness.
We activate the antitumor response: we train the patient's immune cells to recognize the pancreatic tumor and improve their ability to enter its surroundings. The goal is to help the body see what used to escape it.
The method is used as part of comprehensive treatment, together with surgery and drug therapy. Immunotherapy is considered after the physician assesses the stage, extent, and general condition of the patient.
We are honest about the outlook. With this diagnosis, immunotherapy does not replace standard treatment and does not promise quick miracles. Its job is to strengthen the antitumor response and, where possible, bring the disease under longer control.
The body's own cells work more gently than chemotherapy, which matters given the weakened state typical of this diagnosis. The physician selects the final regimen individually after an in-person assessment and review of records.
Working with a 'cold' tumor
Helps the immune system recognize a tumor it usually misses.
Boosting the antitumor response
Trained cells enter the tumor's surroundings and attack it.
Part of comprehensive treatment
Combines with surgery and drug therapy.
Gentle tolerability
Milder than chemotherapy in a weakened state.
An honest outlook
The physician assesses the method's real benefit in each case.
Extracorporeal immunotherapy
We move the immune 'training' process outside the body (ex vivo) — to an environment where we can create the conditions for training immunocompetent cells without creating any risk to your body.
Procedure
We draw your venous blood (up to 90 ml).
Activation (18 hours)
In the laboratory, using our proprietary technology (patents in Russia, the US, and the EU), we incubate the cells with immunomodulatory drugs and xenogeneic antigens. The cells receive a precise target.
Strike
We return the trained cells via subcutaneous injections. A powerful, multi-component immune response is developed.
Consolidation
The maintenance course forms long-term immunological memory, protecting against relapses for years.
Frequently asked questions
How can immunotherapy help with pancreatic cancer?
A pancreatic tumor is usually 'cold': the immune system barely notices it. The method trains immune cells to recognize the tumor and strengthens the antitumor response as part of comprehensive treatment.
What does a 'cold' tumor mean?
It is a tumor that does not attract immune cells and stays invisible to them. The task of immunotherapy is to make it visible to the immune system and trigger an attack.
Does immunotherapy replace surgery and chemotherapy?
No. With this diagnosis the method works together with standard treatment, strengthening it rather than replacing it. The physician defines the regimen after assessing the stage and condition.
How is the treatment program built?
First the physician assesses the stage, the extent of the tumor, prior treatment, and general condition. Based on this data, the program is built and it is decided how to combine immunotherapy with other methods.
How hard is the treatment to tolerate?
The method is tolerated more gently than chemotherapy because the body's own cells do the work. This matters given the weakened state that often accompanies this diagnosis.
Can I come for treatment from another region?
Yes. The clinic is near Moscow (Khimki, Skhodnya) and accepts patients from other regions. The first consultation can be held remotely from your records.
Other directions
Colorectal cancer
Personalized therapy for colon and rectal tumors, improving prognosis and quality of life.
Ovarian cancer
Adoptive therapy opening new treatment possibilities even when chemotherapy standards are exhausted.
Stomach cancer
Safe restoration of antitumor immunity for a targeted fight against cancer cells.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.